Department of Clinical Sciences Intervention and Technology, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.
Nephrol Dial Transplant. 2013 Oct;28(10):2518-26. doi: 10.1093/ndt/gft226. Epub 2013 Jul 30.
Renal function is often estimated using one of several glomerular filtration rate (GFR) estimating equations. However, there is no consensus which estimating equation performs best in patients with advanced renal failure.
We compared the performance of five different estimated GFR (eGFR) equations [Cockcroft-Gault, Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease (CKD) Epidemiology collaboration (CKD-EPI) and Mayo Clinic and Lund-Malmö] with measured GFR (plasma iohexol clearance) in 2098 referred CKD patients with mGFR <30 mL/min/1.73 m(2).
There were 398 patients with an mGFR ≤ 10 mL/min/1.73 m(2), 1974 with a measured GFR (mGFR) 11-20 mL/min/1.73 m(2) and 749 patients with mGFR 21-30 mL/min/1.73 m(2). Across the entire range, the median bias of eGFR was lowest for the Lund-Malmö equation (0.7 mL/min/1.73 m(2)), followed by the CKD-EPI (1.2 mL/min/1.73 m(2)), the MDRD (1.6 mL/min/1.73 m(2)), Mayo Clinic equation (1.7 mL/min/1.73 m(2)) and Cockcroft-Gault equation (4.6 mL/min/1.73 m(2)). The best accuracy within 30% of mGFR was also for Lund-Malmö (76%), while it was similar for CKD-EPI, MDRD and Mayo (65-67%). The Cockcroft-Gault had the worst accuracy of only ∼54%.The median bias was stable across mGFR categories, while the accuracy within 30% of mGFR became worse with decreasing mGFR. All equations performed best among patients with hereditary kidney diseases and tubulointerstitial disease. Accuracy was generally worse for patients >65 years of age and for those with diabetic nephropathy.
In patients with advanced renal failure, the GFR-estimating equations show reasonably good performance on the population level. On the individual patient level, they are inaccurate, especially in elderly patients and those with diabetic nephropathy.
肾功能通常使用几种肾小球滤过率(GFR)估计方程之一进行估计。然而,在肾功能衰竭晚期患者中,哪种估计方程表现最佳尚无共识。
我们比较了 5 种不同的估计肾小球滤过率(eGFR)方程[ Cockcroft-Gault、肾脏病饮食改良试验(MDRD)、慢性肾脏病(CKD)流行病学合作组(CKD-EPI)和梅奥诊所和隆德-马尔默]与 2098 例 mGFR<30mL/min/1.73m(2)的转诊 CKD 患者的实测 GFR(血浆碘海醇清除率)的性能。
有 398 例患者 mGFR≤10mL/min/1.73m(2),1974 例患者 mGFR 11-20mL/min/1.73m(2),749 例患者 mGFR 21-30mL/min/1.73m(2)。在整个范围内,Lund-Malmö 方程的 eGFR 中位数偏倚最低(0.7mL/min/1.73m(2)),其次是 CKD-EPI(1.2mL/min/1.73m(2))、MDRD(1.6mL/min/1.73m(2))、Mayo 诊所方程(1.7mL/min/1.73m(2))和 Cockcroft-Gault 方程(4.6mL/min/1.73m(2))。在 mGFR 的 30%范围内,Lund-Malmö 的准确性也最高(76%),而 CKD-EPI、MDRD 和 Mayo 的准确性相似(65-67%)。Cockcroft-Gault 的准确性最差,仅约为 54%。中位数偏倚在 mGFR 类别中是稳定的,而在 mGFR 的 30%范围内,准确性随着 mGFR 的降低而变差。所有方程在遗传性肾脏疾病和肾小管间质性疾病患者中的表现最好。在年龄大于 65 岁的患者和患有糖尿病肾病的患者中,准确性通常较差。
在肾功能衰竭晚期患者中,GFR 估计方程在人群水平上表现出相当好的性能。在个体患者水平上,它们是不准确的,特别是在老年患者和患有糖尿病肾病的患者中。